Mycophenolate Mofetil in Myasthenia Gravis

NCT00285350 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

80

Enrollment

FED

Sponsor class

Conditions

Myasthenia Gravis

Interventions

DRUG: mycophenolate mofetil

Sponsor

FDA Office of Orphan Products Development

Collaborators

[object Object]